Atrás
Rango del Día
$384.75
$431.80
Rango de 52 Semanas
$324.00
$431.80
Volumen
1
Promedio 50D / 200D
$346.00
/
$346.00
Cierre Anterior
$384.75
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 21.4 | 0.3 |
| P/B | 2.9 | 2.9 |
| ROE % | 13.9 | 3.7 |
| Net Margin % | 10.3 | 3.8 |
| Rev Growth 5Y % | 8.3 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.00
$0.00 – $0.00
|
1.9 B | 0 |
| FY2029 |
$24.09
$23.75 – $24.70
|
1.8 B | 1 |
| FY2028 |
$24.69
$24.35 – $25.32
|
1.7 B | 1 |
Puntos Clave
Revenue grew 8.31% annually over 5 years — modest growth
ROE of 13.91% — decent returns on equity
Debt/Equity of 0.26 — conservative balance sheet
Generating 103.37M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.53%
Capital efficient — spends only 6.30% of revenue on capex
Crecimiento
Revenue Growth (5Y)
8.31%
Revenue (1Y)4.78%
Earnings (1Y)3.81%
FCF Growth (3Y)15.42%
Calidad
Return on Equity
13.91%
ROIC11.52%
Net Margin10.30%
Op. Margin14.89%
Seguridad
Debt / Equity
0.26
Current Ratio1.53
Interest Coverage25.29
Valoración
P/E Ratio
21.37
P/B Ratio2.87
EV/EBITDA15.57
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.78% | Revenue Growth (3Y) | 8.36% |
| Earnings Growth (1Y) | 3.81% | Earnings Growth (3Y) | 11.51% |
| Revenue Growth (5Y) | 8.31% | Earnings Growth (5Y) | 7.45% |
| Profitability | |||
| Revenue (TTM) | 1.46B | Net Income (TTM) | 150.83M |
| ROE | 13.91% | ROA | 7.88% |
| Gross Margin | 35.36% | Operating Margin | 14.89% |
| Net Margin | 10.30% | Free Cash Flow (TTM) | 103.37M |
| ROIC | 11.52% | FCF Growth (3Y) | 15.42% |
| Safety | |||
| Debt / Equity | 0.26 | Current Ratio | 1.53 |
| Interest Coverage | 25.29 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 21.37 | P/B Ratio | 2.87 |
| P/S Ratio | 2.20 | PEG Ratio | 4.51 |
| EV/EBITDA | 15.57 | Dividend Yield | 0.00% |
| Market Cap | 3.22B | Enterprise Value | 3.40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.40B | 1.25B | 1.22B | 1.06B |
| Net Income | 150.83M | 145.29M | 121.30M | 121.97M | 113.16M |
| EPS (Diluted) | 17.98 | 17.34 | 14.38 | 14.43 | 13.40 |
| Gross Profit | 517.74M | 937.60M | 809.60M | 794.99M | 712.85M |
| Operating Income | 218.07M | 227.50M | 184.88M | 179.52M | 167.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.91B | 1.85B | 1.46B | 1.33B | 1.20B |
| Total Liabilities | 788.89M | 805.12M | 545.81M | 494.53M | 476.36M |
| Shareholders' Equity | 1.12B | 1.04B | 900.30M | 839.33M | 724.94M |
| Total Debt | 295.15M | 307.01M | 120.11M | 90.40M | 94.47M |
| Cash & Equivalents | 122.45M | 149.63M | 175.91M | 177.38M | 172.79M |
| Current Assets | 791.59M | 844.12M | 771.48M | 723.53M | 624.67M |
| Current Liabilities | 516.12M | 464.56M | 399.05M | 390.59M | 370.75M |